View Latest Medical and Pharma Bids and Tenders

Market Dialogue Prior To Offering Products For Varicose Vein Treatment

Market Dialogue Prior To Offering Products For Varicose Veins Treatment

Hse 21093 Dps Invitation For Supply Of Infusion Consumables

Market Exploration At The Conclusion Of A Framework Contract For The Exchange Of The Apparatus Infusion Technology At The Hannover Medical School (Mhh)

Market Exploration At The Conclusion Of A Framework Contract For The Exchange Of The Apparatus Infusion Technology At The Hannover Medical School (Mhh)

Supply of Medicine and Medical / Surgical equipments : Imipenem 500mg and Cilastatin 500mg\nInjection\nImipenem 500mg and Cilastatin 500mg\nInjection USP/IP\nEach vial to contain mixture of 500 mg of\nImipenam USP/IP, 500 mg of Cilastatin\nSodium USP/IP and Sodium Bicarbonate\nUSP/IP as sterile dry powder for\nreconstitution for intramuscular and\nintravenous injection or intravenous infusion.\nNote:\n1.The product should be stable for 02 years\nwhen stored under controlled room\ntemperature.\n2.Each vial should be labelled accordingly.\nPacking : One vial etc .

Supply of Medicine and Medical / Surgical equipments : Filgrastim Injection 300micrgoram in\n0.5ml/ml prefilled syringe /vial\nFilgrastim Injection 300microgram in 0.5ml/1ml.\nEach Pre-filled syringe / vial to contain\n300microgram of Filgrastim for subcutaneous\ninjection or intravenous infusion.\nNote:\n1.Shelf life of the product should be minimum\nof 24 months\n2.Each pre-filled syringe/vial should be labelled\naccordingly.\nPacking : One vial in a Pack etc .

Supply of Medicine and Medical / Surgical equipments : Dried Factor IX Fraction 500 IU-600IU vial\nConcentrated, monoclonal,purified and\nDetergent treated Dried factor IX Fraction BP\nor Human Coagulation Factor IX Ph Eur, 500IU\n- 600IU\nEach vial to contain 500 IU - 600IU of\nconcentrated, monoclonal,purified and\nDetergent treated Dried factor IX Fraction BP\nor Human Coagulation Factor IX Ph Eur. The\nproduct containing alternate number of\nUnits/vial also will be considered.\nNote:\n1. Item must include an effective viral\ninactivation steps to ensure that the product is\nsafer for infusions(viral inactivation steps must\nbe given in details)\n2. Date of expiry of the item should be at least\n02 years ahead from the date of receipt of the\nproduct in Sri Lanka.\n3. Tenderer should submit detailed\nspecifications of the product offered.\n4. The product should ensure, at least two\nsteps on virus inactivation as recommended by\nWHO/US.FDA\n5. The donor selection process should be\nspecified by the manufacturer.\n6. Each batch should be certified as free from\nHIV and hepatitis viruses.\n7. Anti viral test methods used for screening for\nHIV and Hepatitis viruses should be declared\nby the manufacturer. The test methods used\nshould be approved by WHO/US.FDA.\n8. The product should be protected from light.\nPacking : One vial etc .

Ad_09/25 Supply Ps. Material (Catheries - Syrights - Velones - Infradies)

Supply of Medicine and Medical / Surgical equipments : Noradrenaline Acid Tartrate 4mg/2ml Ampoule\nNoradrenaline Acid Tartrate Injection BP,4mg in 2ml\nampoule\nEach 2ml ampoule to contain Noradrenaline Acid\nTartrate BP, 4mg equivalent to Noradrenaline base\n1mg/ml, for intravenous infusion\nOR\nNorephinephrine Bitartrate USP,4mg in 2ml ampoule\nEach 2ml ampoule to contain Norephinephrine\nBitartrate USP,4mg equivalent to Norephinephrine\nbase 1mg/ml,for intravenous infusion.\nNote:\n1.The product should be protected from light.\n2.The product should be stable for minmum of 24\nmonths when stored at a temperature range of 28'C-\n32'C\n3.Each ampoule to be labeled accordingly.\nPacking : 10 Ampoules in a Box etc .